Bath & Body Works Stock Plummets to New 52-Week Low at $23.40

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 23.40 as of November 4, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a notable drop in performance, with a decrease of 48.28%, contrasting sharply with the S&P 500's gain of 19.89% during the same period.
The company's financial metrics reflect ongoing challenges, including a price-to-earnings ratio of 7.00 and a concerning return on equity figure. Additionally, Bath & Body Works has reported a negative book value, indicating potential weaknesses in its long-term financial health. The company has also seen a decline in net sales, which have decreased at an annual rate of 8.28% over the last five years.

With a market capitalization of USD 6,299 million, Bath & Body Works continues to face headwinds, including a low inventory turnover ratio and a significant drop in profits. The stock's performance has consistently underperformed against the S&P 500 over the last three years, highlighting the challenges the company is currently navigating.